Norgestimate
From Wikipedia, the free encyclopedia
This article does not cite any references or sources. (February 2007) Please help improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed. |
Norgestimate
|
|
Systematic (IUPAC) name | |
(13-ethyl-17-ethynyl-3-hydroxyimino- 1,2,6,7,8,9,10,11,12,14,15,16- dodecahydrocyclopenta[a] phenanthren-17-yl) acetate | |
Identifiers | |
CAS number | |
ATC code | G03 |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C23H31NO3 |
Mol. mass | 369.497 g/mol |
SMILES | & |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | 12-30 hours |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Norgestimate is a molecule used in hormonal contraceptives.
Norgestimate is a form of progesterone, which is a female hormone important for the regulation of ovulation and menstruation. Norgestimate is used with estradiol (a female sex hormone that is involved in the development and maintenance of the female reproductive system), to treat the symptoms of menopause.